| Date | Time | Source | Headline | Symbol | Company |
| 01/16/2024 | 1:49AM | Dow Jones News | Roche's Cancer Injection Tecentriq SC Gets European Commission Approval | USOTC:RHHBY | Roche Holdings Ltd AG (QX) |
| 01/10/2024 | 8:45AM | InvestorsHub NewsWire | GLP-1: Beyond Diabetes, a Blockbuster Horizon Beckons | USOTC:RHHBY | Roche Holdings Ltd AG (QX) |
| 12/29/2023 | 5:07PM | Dow Jones News | LumiraDx Agrees to Sell Point-of-Care Tech Platform to Roche | USOTC:RHHBY | Roche Holdings Ltd AG (QX) |
| 12/19/2023 | 10:27AM | Dow Jones News | Roche's Xolair Granted FDA Priority Review | USOTC:RHHBY | Roche Holdings Ltd AG (QX) |
| 12/11/2023 | 10:31AM | Dow Jones News | Poseida Therapeutics Shares Climb on Positive Data for Blood Cancer Treatment | USOTC:RHHBY | Roche Holdings Ltd AG (QX) |
| 12/08/2023 | 12:56PM | Dow Jones News | Roche Obtains Positive Data on Early-Stage Breast Cancer Treatment | USOTC:RHHBY | Roche Holdings Ltd AG (QX) |
| 12/08/2023 | 12:38PM | Dow Jones News | Roche's Inavolisib Breast Cancer Drug Gets Positive Results | USOTC:RHHBY | Roche Holdings Ltd AG (QX) |
| 12/06/2023 | 5:14AM | Dow Jones News | Merck Shares Slump After Multiple Sclerosis Drug Fails in Late-Stage Trials | USOTC:RHHBY | Roche Holdings Ltd AG (QX) |
| 12/05/2023 | 1:54AM | Dow Jones News | Roche's Inavolisib Breast Cancer Drug Shows Promise in Late-Stage Study | USOTC:RHHBY | Roche Holdings Ltd AG (QX) |
| 12/04/2023 | 10:12AM | Dow Jones News | Trending: Roche to Buy Carmot Therapeutics in Deal Worth Up to $3.1 Billion | USOTC:RHHBY | Roche Holdings Ltd AG (QX) |
| 12/04/2023 | 6:34AM | Dow Jones News | Roche to Buy Carmot Therapeutics for Up to $3.1 Billion in Bet on Obesity Treatments -- Update | USOTC:RHHBY | Roche Holdings Ltd AG (QX) |
| 12/04/2023 | 5:55AM | IH Market News | Alaska Air Acquires Hawaiian Holdings, Spotify Cuts 1,500 Jobs, Uber’s S&P 500 Entry, and More | USOTC:RHHBY | Roche Holdings Ltd AG (QX) |
| 12/04/2023 | 1:47AM | Dow Jones News | Roche Strikes Deal to Buy Drug Developer Carmot Therapeutics for $2.7 Billion | USOTC:RHHBY | Roche Holdings Ltd AG (QX) |
| 11/21/2023 | 11:06AM | Dow Jones News | Roche's Genentech, Nvidia Team Up to Accelerate Drug Discovery With AI | USOTC:RHHBY | Roche Holdings Ltd AG (QX) |
| 11/07/2023 | 5:14PM | Edgar (US Regulatory) | Form 3 - Initial statement of beneficial ownership of securities | USOTC:RHHBY | Roche Holdings Ltd AG (QX) |
| 10/31/2023 | 2:26AM | Dow Jones News | Roche Says Late-Stage Muscular Dystrophy Trial Didn't Meet Main Goal | USOTC:RHHBY | Roche Holdings Ltd AG (QX) |
| 10/27/2023 | 1:40AM | Dow Jones News | Roche Gets FDA Approval for Vabysmo as Retinal Vein Occlusion Treatment | USOTC:RHHBY | Roche Holdings Ltd AG (QX) |
| 10/23/2023 | 3:41PM | Dow Jones News | Trending: Roche to Buy Telavant From Roivant and Pfizer | USOTC:RHHBY | Roche Holdings Ltd AG (QX) |
| 10/23/2023 | 4:16AM | Dow Jones News | Roche to Buy Telavant From Roivant, Pfizer in Deal Worth Up to $7.25 Billion -- Update | USOTC:RHHBY | Roche Holdings Ltd AG (QX) |
| 10/23/2023 | 1:50AM | Dow Jones News | Roche to Buy Telavant From Roivant Sciences and Pfizer in $7.25 Billion Deal | USOTC:RHHBY | Roche Holdings Ltd AG (QX) |
| 10/19/2023 | 5:55AM | Dow Jones News | Roche Shares Fall on Lower Sales Due to Currency Hit | USOTC:RHHBY | Roche Holdings Ltd AG (QX) |
| 10/19/2023 | 1:48AM | Dow Jones News | Roche Backs Guidance After Sales Fall | USOTC:RHHBY | Roche Holdings Ltd AG (QX) |
| 10/18/2023 | 2:14AM | Dow Jones News | Roche Lung Cancer Drug Reduced Risk of Recurrence, Death in Late-Stage Trial | USOTC:RHHBY | Roche Holdings Ltd AG (QX) |
| 10/18/2023 | 1:54AM | Dow Jones News | Roche's Elecsys IL-6 Test Approved for Diagnosis of Neonatal Sepsis | USOTC:RHHBY | Roche Holdings Ltd AG (QX) |
| 09/29/2023 | 8:15AM | Dow Jones News | AbbVie: Phase 3 Venetoclax/Dexamethasone Study Falls Short in Multiple Myeloma | USOTC:RHHBY | Roche Holdings Ltd AG (QX) |
| 09/27/2023 | 7:59AM | Dow Jones News | Ionis, Roche Set New Pact Targeting Alzheimer's, Huntington's | USOTC:RHHBY | Roche Holdings Ltd AG (QX) |
| 09/20/2023 | 8:45AM | InvestorsHub NewsWire | Pathways to Progress: How Orphan Drug Designation Sparks Biotech Transformation | USOTC:RHHBY | Roche Holdings Ltd AG (QX) |
| 09/06/2023 | 1:52AM | Dow Jones News | Roche's Blood Disorder Drug Crovalimab Takes Step Toward FDA Approval | USOTC:RHHBY | Roche Holdings Ltd AG (QX) |
| 09/01/2023 | 2:04AM | Dow Jones News | Roche Lung Cancer Drug Shows Promise in Phase 3 Trial | USOTC:RHHBY | Roche Holdings Ltd AG (QX) |
| 08/29/2023 | 5:51AM | Dow Jones News | Roche's Tecentriq Intravenous Cancer Therapy Gets UK Approval | USOTC:RHHBY | Roche Holdings Ltd AG (QX) |